A. G. P. Initiates Chromocell Therapeutics(CHRO.US) With Buy Rating, Announces Target Price $8.5

A. G. P. analyst James Molloy initiates coverage on $Chromocell Therapeutics(CHRO.US)$ with a buy rating, and sets the target price at $8.5.According to TipRanks data, the analyst has a success rate o

moomoo NewsJun 19 13:31 ET · Ratings

Alliance Global Partners Initiates Coverage On Chromocell Therapeutics With Buy Rating

Alliance Global Partners analyst James Molloy initiates coverage on Chromocell Therapeutics (AMEX:CHRO) with a Buy rating.

BenzingaJun 18 13:28 ET

Chromocell Therapeutics Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/18/2024 — Alliance Global Partners Initiates Coverage On → Buy

BenzingaJun 18 13:27 ET

Express News | Chromocell Therapeutics Corp : Alliance Global Partners Initiates Coverage With Buy Rating; Target Price $8.50

ReutersJun 18 07:05 ET

12 Health Care Stocks Moving In Wednesday's Intraday Session

GainersInnovative Eyewear (NASDAQ:LUCY) stock increased by 173.2% to $1.12 during Wednesday's regular session. The market value of their outstanding shares is at $19.6 million. Reshape Lifesciences (N

BenzingaMay 29 12:31 ET

Chromocell Therapeutics | 10-Q: Quarterly report

SEC announcementMay 15 17:10 ET · Announcements